5-(5-fluoro-3-pyridinyl)-3-propan-2-yl-N-[2-(5-propyl-1H-pyrazol-4-yl)ethyl]pyrazolo[1,5-a]pyrimidin-7-amine
C22H26FN7 — CID 142460309
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(5-fluoro-3-pyridinyl)-3-propan-2-yl-N-[2-(5-propyl-1H-pyrazol-4-yl)ethyl]pyrazolo[1,5-a]pyrimidin-7-amine
5-(5-fluoro-3-pyridinyl)-3-propan-2-yl-N-[2-(5-propyl-1H-pyrazol-4-yl)ethyl]pyrazolo[1,5-a]pyrimidin-7-amine (PubChem CID 142460309) has the molecular formula C22H26FN7 and a molecular weight of 407.50 g/mol. Its IUPAC name is 5-(5-fluoro-3-pyridinyl)-3-propan-2-yl-N-[2-(5-propyl-1H-pyrazol-4-yl)ethyl]pyrazolo[1,5-a]pyrimidin-7-amine.
Molecular Properties
| Compound Name | 5-(5-fluoro-3-pyridinyl)-3-propan-2-yl-N-[2-(5-propyl-1H-pyrazol-4-yl)ethyl]pyrazolo[1,5-a]pyrimidin-7-amine |
|---|---|
| PubChem CID | 142460309 |
| Molecular Formula | C22H26FN7 |
| Molecular Weight | 407.50 g/mol |
| Exact Mass | 407.22 |
| IUPAC Name | 5-(5-fluoro-3-pyridinyl)-3-propan-2-yl-N-[2-(5-propyl-1H-pyrazol-4-yl)ethyl]pyrazolo[1,5-a]pyrimidin-7-amine |
| SMILES | CCCc1[nH]ncc1CCNc1cc(-c2cncc(F)c2)nc2c(C(C)C)cnn12 |
| InChI | InChI=1S/C22H26FN7/c1-4-5-19-15(11-26-29-19)6-7-25-21-9-20(16-8-17(23)12-24-10-16)28-22-18(14(2)3)13-27-30(21)22/h8-14,25H,4-7H2,1-3H3,(H,26,29) |
| InChIKey | RRZITSBZXFVAPU-UHFFFAOYSA-N |
| XLogP | 4.38 |
| TPSA | 83.79 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 407.50 |
| LogP ≤ 5 | 4.38 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142460309 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.